Navigation Links
Fellowships for outstanding research in drug use and HIV awarded by IAS and NIDA
Date:7/12/2011

Wednesday July 13, 2011 (Geneva, Switzerland) -- The International AIDS Society (IAS) and the US National Institute on Drug Abuse (NIDA) today announced the recipients of their third annual joint research fellowships. Recipients of the prestigious awards will receive US$75,000 each to advance scientific understanding of the linkages between drug use and HIV while fostering multinational research.

Young researchers from China and Indonesia will be awarded post-doctoral fellowships to pursue outstanding research in the field. (1) IAS/NIDA research fellowships are awarded to junior scientists for 18 months for post-doctoral training and to well-established HIV researchers for eight months of professional development, both at institutes excelling in research on drug use and HIV.

Presentation of the IAS/NIDA fellowships will take place in a fortnight on Wednesday 20 July 2011 at the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention at the Auditorium Parco della Musica in Rome, Italy.

The fellowships ceremony will take place immediately before the Plenary Session (08:45-11:00) where NIDA Director Dr Nora D Volkow will give a keynote presentation Ending HIV Transmission Among Drug Users by 2015.

"The innovative research projects that will be implemented by these talented scientists in different disciplines clinical science, law and public health cover multiple areas of research needed to improve strategies targeting HIV infections related to drug use," said IAS President Dr Elly Katabira.

Drug use is a global problem that brings with it greatly increased risk for HIV infection. Approximately three million of the estimated 15.9 million people aged 15 to 64 who injected drugs in 2008 are living with HIV. A total of 120 countries have reported cases of HIV among people who inject drugs. Injecting drug use represents one of the predominant modes of transmission of HIV in Eastern Europe and Central Asia, where HIV prevalence among people who inject drugs is higher than 40 per cent in some countries. Use of other drugs, such as cocaine and methamphetamine, even without injection, is also associated with increased HIV risk behaviours.

"If you don't treat drug dependency, the likelihood of an individual being infected by HIV becomes higher. We need to treat drug users if we want to treat HIV," said Dr Volkow. "In fact, preventing and treating drug use is treating HIV."

Drug-related HIV/AIDS epidemics have followed the spread of cocaine injecting in Latin America and heroin injecting in Asia in the 1980s and the massive spread of injecting heroin and other opiates in Eastern Europe in the 1990s.

Overall growth in numbers of new HIV infections has slowed in most regions of the world. One exception to this trend, however, is the continued growth in numbers of HIV infections linked to injecting drug use, especially in Eastern Europe, Central Asia and more recently, sub-Saharan Africa.


'/>"/>

Contact: Lindsey Rodger
lindsey.rodger@iasociety.org
International AIDS Society
Source:Eurekalert

Related medicine news :

1. The New York Stem Cell Foundation awards fellowships to 7 innovative stem cell scientists
2. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 12 top young scientists
3. University of Toronto scholars receive prestigious New Directions Fellowships
4. Anti-HIV gel leadership team acknowledged for outstanding achievement in world health
5. Outstanding high school students receive AGA Research Foundation Fellowship Awards
6. Outstanding quality of science at 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) underlines conference goal of translating HIV research into practice
7. AACR recognizes the outstanding achievements of Pier Paolo Pandolfi
8. ABTA names Ryan Salinas outstanding 10 summer medical student fellow
9. Ming T. Tsuang recognized with NARSAD outstanding achievement award for schizophrenia research
10. SWOG names 5 cancer researchers outstanding Young Investigators
11. SNM honors outstanding contributors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
Breaking Medicine Technology: